Ascendis Pharma A (ASND) Current Leases (2019 - 2025)

Ascendis Pharma A has disclosed Current Leases across 7 years of filings, most recently posting $176.4 million for Q4 2025.

• Current Leases for Q4 2025 came in at $176.4 million, up 77.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $176.4 million (up 77.42% YoY), and the FY2025 annual result was $176.4 million, up 77.42% from the prior year.
• Current Leases came in at $176.4 million for Q4 2025 at Ascendis Pharma A, up from $99.4 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $176.4 million in Q4 2025 to a low of $15.3 million in Q4 2023.
• The 5-year median for Current Leases is $108.0 million (2021), against an average of $104.5 million.
• Across the five-year window, Current Leases slumped 84.3% in 2023 and surged 550.67% in 2024, its largest moves.
• Ascendis Pharma A's Current Leases stood at $120.1 million in 2021, then retreated by 18.94% to $97.3 million in 2022, then plunged by 84.3% to $15.3 million in 2023, then soared by 550.67% to $99.4 million in 2024, then surged by 77.42% to $176.4 million in 2025.
• The last three Current Leases figures came in at $176.4 million (Q4 2025), $99.4 million (Q4 2024), and $15.3 million (Q4 2023), per Business Quant data.